Lyomit 2 Injection
Marketer
United Biotech Pvt Ltd
Salt Composition
Mitomycin (2mg)
Overview Lyomit 2 Injection
Oncaspar injection treats specific pancreatic, breast, lung, and stomach cancers. It's administered intravenously, either solely or as part of combined chemotherapy regimens, inhibiting cancerous cell proliferation and ultimately causing their demise. Dosage and frequency are determined by your physician based on your condition and may vary. Strict adherence to your doctor's instructions is vital; improper usage or overdose can lead to severe adverse reactions. Therapeutic effects might not be immediately apparent, requiring weeks or months; discontinue only under medical guidance. Common side effects include anemia, leukopenia, increased bleeding risk, anorexia, nausea, and vomiting; report any concerning symptoms to your doctor for potential mitigation strategies. Prior to treatment, disclose any existing blood, kidney, liver, or respiratory issues. This medication lowers blood cell counts, increasing infection vulnerability. Regular blood tests monitoring blood cell levels, kidney, liver, and heart function are mandatory throughout treatment. Consistent use of effective contraception by both partners is crucial to prevent pregnancy.
Uses of Lyomit 2 Injection
Malignancies of the pancreas, breast, lung (non-small cell type), and stomach.
Major Benefits of Lyomit 2 Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Lyomit 2 Injection:
- Anemia (low number of red blood cells)
- Decreased white blood cell count
- Increased bleeding tendency
- Loss of appetite
- Nausea
- Vomiting
- Feeling of discomfort
- Low blood platelets
- Weight loss
- Rash
How to use Lyomit 2 Injection:
Administering this medication will be handled by your physician or their qualified staff; self-medication is strictly prohibited.
How Lyomit 2 Injection works:
Lyomit 2 Injection is an antineoplastic agent that targets cancer cells. Its mechanism of action involves disrupting the DNA of these cells, thereby halting their proliferation and growth.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Lyomit 2 Injection and alcohol may lead to significant sleepiness.
PregnancyUNSAFE
Administration of Lyomit 2 Injection is strongly contraindicated during pregnancy. Pregnant individuals should consult their physician; research in animal models and pregnant women reveals substantial adverse effects on fetal development.
Breast feedingCAUTION
Administering Lyomit 2 Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
Administering Lyomit 2 Injection might induce adverse reactions impacting driving capabilities. Nausea and vomiting, potential side effects of Lyomit 2 Injection, can significantly slow reflexes, rendering safe vehicle operation difficult.
KidneyCAUTION
For individuals with impaired kidney function, Lyomit 2 Injection requires careful administration and may necessitate dosage modification. Physician consultation is advised. Lyomit 2 Injection is contraindicated in those with terminal kidney failure.
LiverCAUTION
Individuals with liver impairment should use Lyomit 2 Injection cautiously, potentially requiring a modified dosage. Medical advice is necessary. Lyomit 2 Injection may be unsuitable for certain patients with hepatic dysfunction.
What if you forget to take Lyomit 2 Injection :
NA
Facts to Know About Lyomit 2 Injection
| Label | Value |
|---|---|
| Chemical Classification | Cancer-Fighting Antibiotics |
| Developing Habits | No. |
| Treatment Category | Cancer Therapeutics |
| Active Class | Cytotoxic alkaloids |
3,018 People bought this recently